Arca
Skip to content
Tools
Tools

NeuroStar Advanced Therapy System (Version 3.8)

Transcranial Magnetic Stimulator. 510(k) K233621, from Neuronetics (Malvern, PA). Product code OBP, class 2.

As of Nov 21, 2026, K233621 is an FDA 510(k) held by Neuronetics, substantially equivalent on Dec 13, 2023 after 30 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 30 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate
  • BTL-699K260691 · BTL Industries, Inc. · Aug 23, 2026

Recalls

Recalls FDA ties to K233621, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Aug 24, 2026Z-0142-2027Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly.Open

Other OBP clearances

The newest 510(k)s for the same product code; their median review was 178 days; see every OBP device

Record

Type
Special
Received
Nov 13, 2023
Review panel
Neurology
Regulation
21 CFR 882.5805

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.